Efficacy and safety evaluation of Fanhdi® , a plasma-derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study.
Victor Jimenez YusteLaura NúñezMaria Teresa Alvarez-RomanMonica Martin-SalcesSaturnino HayaAugusto B FedericiCarlota GrifolsEsther MairalMireia TorresAntonio PáezPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)